Details for New Drug Application (NDA): 210317
✉ Email this page to a colleague
The generic ingredient in OCTREOTIDE ACETATE is octreotide acetate. There are twenty drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the octreotide acetate profile page.
Summary for 210317
Tradename: | OCTREOTIDE ACETATE |
Applicant: | Teva Pharms Usa Inc |
Ingredient: | octreotide acetate |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Medical Subject Heading (MeSH) Categories for 210317
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | EQ 10MG BASE/VIAL | ||||
Approval Date: | Dec 5, 2023 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | EQ 20MG BASE/VIAL | ||||
Approval Date: | Dec 5, 2023 | TE: | AB | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | EQ 30MG BASE/VIAL | ||||
Approval Date: | Dec 5, 2023 | TE: | AB | RLD: | No |
Complete Access Available with Subscription